As we await the FDA’s results to decide on the outcome of the aducanumab trial, this year is clearly a critical year for all those working on .. Read more neurodegenerative R&D. Back in an all new digital format, the 9th Annual Neurodegenerative Drug Development Summit will once again prove to be the industry’s definitive and unrivalled forum. This year, we will focus on revealing hot areas of innovation in drug discovery for a range of neurodegenerative diseases and discuss promising approaches to combating translational challenges through shining the light on pioneering companies leading the way to meet this dire medical need. “Great meeting that has the right balance of science, drug discovery & development, and networking” - Jonathan Levenson, Senior Director, Proclara BioSciences. “High level, focused meeting, with overall very interesting presentations and discussion by decision makers in CNS R&D” - Johan Luthman, VP of Clinical Development, Eisai.
- Share your Experience